Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nat Genet. 2011 Mar;43(3):264-8. doi: 10.1038/ng.759. Epub 2011 Jan 23.
Development, differentiation and response to environmental stimuli are characterized by sequential changes in cellular state initiated by the de novo binding of regulated transcriptional factors to their cognate genomic sites. The mechanism whereby a given regulatory factor selects a limited number of in vivo targets from a myriad of potential genomic binding sites is undetermined. Here we show that up to 95% of de novo genomic binding by the glucocorticoid receptor, a paradigmatic ligand-activated transcription factor, is targeted to preexisting foci of accessible chromatin. Factor binding invariably potentiates chromatin accessibility. Cell-selective glucocorticoid receptor occupancy patterns appear to be comprehensively predetermined by cell-specific differences in baseline chromatin accessibility patterns, with secondary contributions from local sequence features. The results define a framework for understanding regulatory factor-genome interactions and provide a molecular basis for the tissue selectivity of steroid pharmaceuticals and other agents that intersect the living genome.
发育、分化和对环境刺激的反应的特点是细胞状态的顺序变化,由调节转录因子与它们的同源基因组位点的从头结合引发。特定的调节因子如何从无数潜在的基因组结合位点中选择有限数量的体内靶标尚不确定。在这里,我们表明,多达 95%的糖皮质激素受体(一种典型的配体激活转录因子)的新基因组结合被靶向到预先存在的可及染色质焦点。因子结合总是增强染色质的可及性。糖皮质激素受体的细胞选择性占据模式似乎完全由基础染色质可及性模式的细胞特异性差异预先确定,局部序列特征有次要贡献。该结果为理解调节因子-基因组相互作用提供了一个框架,并为甾体药物和其他与活基因组交叉的试剂的组织选择性提供了分子基础。